vs

Side-by-side financial comparison of BuzzFeed, Inc. (BZFD) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Health Catalyst, Inc. is the larger business by last-quarter revenue ($74.7M vs $56.5M, roughly 1.3× BuzzFeed, Inc.). BuzzFeed, Inc. runs the higher net margin — -47.4% vs -121.9%, a 74.5% gap on every dollar of revenue. On growth, BuzzFeed, Inc. posted the faster year-over-year revenue change (0.6% vs -6.2%). Health Catalyst, Inc. produced more free cash flow last quarter ($9.6M vs $-12.0M). Over the past eight quarters, BuzzFeed, Inc.'s revenue compounded faster (23.6% CAGR vs -0.0%).

BuzzFeed, Inc. is an American Internet media, news, and entertainment company with a focus on digital media. Based in New York City, BuzzFeed was founded in 2006 by Jonah Peretti and John S. Johnson III to focus on tracking viral content. Kenneth Lerer, co-founder and chairman of The Huffington Post, started as a co-founder and investor in BuzzFeed and is now the executive chairman.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

BZFD vs HCAT — Head-to-Head

Bigger by revenue
HCAT
HCAT
1.3× larger
HCAT
$74.7M
$56.5M
BZFD
Growing faster (revenue YoY)
BZFD
BZFD
+6.8% gap
BZFD
0.6%
-6.2%
HCAT
Higher net margin
BZFD
BZFD
74.5% more per $
BZFD
-47.4%
-121.9%
HCAT
More free cash flow
HCAT
HCAT
$21.6M more FCF
HCAT
$9.6M
$-12.0M
BZFD
Faster 2-yr revenue CAGR
BZFD
BZFD
Annualised
BZFD
23.6%
-0.0%
HCAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BZFD
BZFD
HCAT
HCAT
Revenue
$56.5M
$74.7M
Net Profit
$-26.8M
$-91.0M
Gross Margin
Operating Margin
-43.7%
-115.3%
Net Margin
-47.4%
-121.9%
Revenue YoY
0.6%
-6.2%
Net Profit YoY
-186.4%
-340.3%
EPS (diluted)
$-0.72
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BZFD
BZFD
HCAT
HCAT
Q4 25
$56.5M
$74.7M
Q3 25
$46.3M
$76.3M
Q2 25
$46.4M
$80.7M
Q1 25
$36.0M
$79.4M
Q4 24
$56.2M
$79.6M
Q3 24
$55.6M
$76.4M
Q2 24
$41.1M
$75.9M
Q1 24
$37.0M
$74.7M
Net Profit
BZFD
BZFD
HCAT
HCAT
Q4 25
$-26.8M
$-91.0M
Q3 25
$-7.4M
$-22.2M
Q2 25
$-10.8M
$-41.0M
Q1 25
$-12.7M
$-23.7M
Q4 24
$31.0M
$-20.7M
Q3 24
$2.1M
$-14.7M
Q2 24
$-7.5M
$-13.5M
Q1 24
$-35.7M
$-20.6M
Gross Margin
BZFD
BZFD
HCAT
HCAT
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
BZFD
BZFD
HCAT
HCAT
Q4 25
-43.7%
-115.3%
Q3 25
-12.9%
-22.9%
Q2 25
-7.5%
-46.0%
Q1 25
-38.1%
-25.4%
Q4 24
7.0%
-22.0%
Q3 24
2.8%
-17.9%
Q2 24
-13.6%
-20.8%
Q1 24
-63.4%
-30.5%
Net Margin
BZFD
BZFD
HCAT
HCAT
Q4 25
-47.4%
-121.9%
Q3 25
-16.1%
-29.1%
Q2 25
-23.3%
-50.8%
Q1 25
-35.2%
-29.9%
Q4 24
55.2%
-26.0%
Q3 24
3.8%
-19.3%
Q2 24
-18.2%
-17.8%
Q1 24
-96.5%
-27.6%
EPS (diluted)
BZFD
BZFD
HCAT
HCAT
Q4 25
$-0.72
$-1.29
Q3 25
$-0.20
$-0.32
Q2 25
$-0.28
$-0.59
Q1 25
$-0.33
$-0.35
Q4 24
$0.86
$-0.33
Q3 24
$0.05
$-0.24
Q2 24
$-0.20
$-0.23
Q1 24
$-0.98
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BZFD
BZFD
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$8.5M
$95.7M
Total DebtLower is stronger
$153.3M
Stockholders' EquityBook value
$49.4M
$245.8M
Total Assets
$188.1M
$502.6M
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BZFD
BZFD
HCAT
HCAT
Q4 25
$8.5M
$95.7M
Q3 25
$34.3M
$91.5M
Q2 25
$29.7M
$97.3M
Q1 25
$34.3M
$342.0M
Q4 24
$22.4M
$392.0M
Q3 24
$53.7M
$387.3M
Q2 24
$45.5M
$308.3M
Q1 24
$44.5M
$327.8M
Total Debt
BZFD
BZFD
HCAT
HCAT
Q4 25
$153.3M
Q3 25
$153.1M
Q2 25
$153.0M
Q1 25
$382.9M
Q4 24
$382.4M
Q3 24
$345.0M
Q2 24
Q1 24
Stockholders' Equity
BZFD
BZFD
HCAT
HCAT
Q4 25
$49.4M
$245.8M
Q3 25
$75.9M
$331.9M
Q2 25
$81.1M
$347.5M
Q1 25
$93.8M
$376.8M
Q4 24
$104.8M
$365.2M
Q3 24
$71.7M
$355.0M
Q2 24
$67.2M
$357.0M
Q1 24
$73.7M
$357.2M
Total Assets
BZFD
BZFD
HCAT
HCAT
Q4 25
$188.1M
$502.6M
Q3 25
$211.2M
$587.1M
Q2 25
$210.4M
$616.2M
Q1 25
$203.2M
$891.5M
Q4 24
$221.4M
$858.9M
Q3 24
$276.5M
$813.0M
Q2 24
$272.9M
$691.7M
Q1 24
$299.0M
$695.1M
Debt / Equity
BZFD
BZFD
HCAT
HCAT
Q4 25
0.62×
Q3 25
0.46×
Q2 25
0.44×
Q1 25
1.02×
Q4 24
1.05×
Q3 24
0.97×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BZFD
BZFD
HCAT
HCAT
Operating Cash FlowLast quarter
$-11.7M
$9.9M
Free Cash FlowOCF − Capex
$-12.0M
$9.6M
FCF MarginFCF / Revenue
-21.2%
12.9%
Capex IntensityCapex / Revenue
0.5%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.7M
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BZFD
BZFD
HCAT
HCAT
Q4 25
$-11.7M
$9.9M
Q3 25
$1.7M
$-464.0K
Q2 25
$-10.1M
$-9.0M
Q1 25
$1.3M
$280.0K
Q4 24
$-4.6M
$-3.5M
Q3 24
$9.6M
$6.2M
Q2 24
$-12.4M
$1.6M
Q1 24
$-13.3M
$10.3M
Free Cash Flow
BZFD
BZFD
HCAT
HCAT
Q4 25
$-12.0M
$9.6M
Q3 25
$892.0K
$-719.0K
Q2 25
$-10.5M
$-9.2M
Q1 25
$956.0K
$-390.0K
Q4 24
$-4.7M
$-3.9M
Q3 24
$9.3M
$5.5M
Q2 24
$-12.5M
$1.3M
Q1 24
$-13.4M
$10.1M
FCF Margin
BZFD
BZFD
HCAT
HCAT
Q4 25
-21.2%
12.9%
Q3 25
1.9%
-0.9%
Q2 25
-22.7%
-11.4%
Q1 25
2.7%
-0.5%
Q4 24
-8.4%
-4.9%
Q3 24
16.7%
7.2%
Q2 24
-30.5%
1.7%
Q1 24
-36.2%
13.5%
Capex Intensity
BZFD
BZFD
HCAT
HCAT
Q4 25
0.5%
0.4%
Q3 25
1.8%
0.3%
Q2 25
1.0%
0.3%
Q1 25
1.1%
0.8%
Q4 24
0.3%
0.5%
Q3 24
0.5%
0.9%
Q2 24
0.3%
0.4%
Q1 24
0.2%
0.3%
Cash Conversion
BZFD
BZFD
HCAT
HCAT
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.15×
Q3 24
4.59×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BZFD
BZFD

Advertising$25.6M45%
Commerce And Other$16.3M29%
Content$14.7M26%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons